|
1.
Share Success: Letters From Readers
Letter I: From Marlene
Received
at Testimonial Submit Form Tuesday, August 13, 2019 at 15:34:19
(Unedited)
Hi, my name is Marlene.
In 2011, I had a terrible fall and shattered my right hip. I had a complete hip replacement. It never felt right but doctors could not find a problem.
I was diagnosed with osteoporosis and given a prolia injection every six months. While in the hospital I read that prolia caused femoral fractures.
While on the internet I came upon EZorb and decided to try it. I had nothing to lose.
In December 2019, I started taking the recommended dosage. My numbers are still bad but there was a noticeable improvement from -3 to -2.5.
I started off in a wheelchair, then a walker and am now using a cane. I can now walk
short distances without any assistance but find my balance is off. Will my balance gradually improve?
I will continue taking EZorb.
Letter II: From Lori T., Wellness Store Owner
Received
at sharesuccess @ ezorbonline.com Saturday, August 3, 2019 at 03:41:52
(Unedited)
EZorb is really helping me. My teeth are solid white again.
I was told I was losing my enamel and can't ever get it back. I started taking EZorb for my back and it is much better also but then I noticed my teeth and could not believe the difference.
I love this stuff. I know a lot of my client who would love this also.
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 120,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort.
2.
Research News: Does Resting Heart Rate Impact Type 2 Diabetes Risk?
Researchers have used Mendelian randomization analysis to demonstrate a shared etiology between resting heart rate (RHR) and the risk for type 2 diabetes.
Liming Liang (Harvard TH Chan School of Public Health, Boston, Massachusetts, USA) and team found each 10 beats/minute increase in RHR to be responsible for a 12% increase in the risk for type 2 diabetes.
There was also a causal effect in the reverse direction, with type 2 diabetes adding an additional estimated 0.32 beats/minute to RHR, they report in the Journal of the American College of Cardiology.
Patricia Munroe (Queen Mary University of London, UK) and co-authors of a linked editorial describe the research as "a very first step" in understanding these complex relationships, adding that "the bi-directional causality especially raises questions, and further validation will be necessary before beginning to address any clinical implications of the work."
The researchers used data from 428,250 people in the UK Biobank who were not using beta blockers to identify 437 genetic variants that were significantly associated with RHR, 327 of which had not been previously reported.
The team compared these genetic data with summary statistics from the DIAGRAM Consortium, which provided data from 74,124 people with type 2 diabetes and 824,006 without who participated in 32 genome-wide association studies.
This showed significant genetic correlation between RHR and type 2 diabetes, and also between RHR and six of eight metabolic parameters studied, namely, fasting insulin, fasting glucose, waist-to-hip ratio, BMI, triglycerides, and high-density lipoprotein (HDL) cholesterol.
Levels of these metabolic indices increased as RHR did, with the exception of HDL cholesterol, which fell. Total and low-density lipoprotein cholesterol were not associated with RHR.
In addition to being causally related to diabetes, RHR was also associated with waist-to-hip ratio, and vice versa, but other metabolic parameters were only associated in the reverse direction, e.g., higher fasting glucose had a significant causal effect on higher RHR, but the reverse was not true.
The researchers identified seven genes that independently affected both RHR and the risk for type 2 diabetes, and so likely to play a role in the etiology of both processes. These were SMARCAD1, RP11-53O19.3, CTC-498M16.4, PDE8B, AKTIP, KDM4B, and TSHZ3.
The functions of these genes suggest a role for telomere function, epigenetic regulation of energy metabolism, and vascular endothelial aging in the etiology of RHR and type 2 diabetes, say Liang and team.
Munroe and co-authors note in their editorial that functional studies of these shared genes may yield useful knowledge, and the "promise of potential drug intervention" based on such research is "alluring."
But they caution that lifelong genetic exposure as assessed in Mendelian randomization studies "may not translate to short- to medium-term intervention from pharmacological therapy in reducing type 2 diabetes risk."
Original article was published in J Am Coll Cardiol 2019; 74: 2162–2174.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
